Elsevier

Survey of Ophthalmology

Volume 26, Issue 1, July–August 1981, Pages 1-21
Survey of Ophthalmology

Review
Graves' ophthalmopathy. A clinical and immunologic review

https://doi.org/10.1016/0039-6257(81)90120-XGet rights and content

Abstract

Graves' thyroid disease and the orbitopathy which often accompanies it have puzzled physicians and scientists for more than 150 years. Although certain histopathological features have been documented, it is not known what mechanisms are responsible for the systemic and/or ocular disorders. The ocular condition characteristic of Graves' disease may exist in the absence of clinical or biochemical evidence of thyroid dysfunction, and when the systemic and ocular conditions exist together, they may follow completely different clinical courses. Because the relationship between the thyroid disorder and the orbitopathy is not established, the authors refer not to “thyroid ophthalmopathy,” but to “Graves' ophthalmopathy.” In this review, histopathological features of Graves' ophthalmopathy are reviewed. The differential diagnosis of the ophthalmopathy and approaches to its evaluation are discussed, notably the T-4 radioimmunoassay, T-3 resin uptake and TSH tests, as well as CT scanning and ultrasonography. The characteristics of Classes 0–6 ophthalmopathy are outlined and the management of cases in each class is considered. The possible immunological basis for Graves' ophthalmopathy is also reviewed.

References (134)

  • D.E. Lyons

    Postural changes in intraocular pressure in dysthyroid exophthalmos

    Trans Ophthalmol Soc UK

    (1971)
  • J.M. McKenzie

    Long-acting thyroid stimulator of Graves' disease

  • J.L. Pappen et al.

    Pinealomas and tumors of the posterior portion of the third ventricle

    J Neurosurg

    (1968)
  • D.D. Adams et al.

    Stimulation of the human thyroid by infusions of plasma containing LATS protector

    J Clin Endocrinol Metab

    (1974)
  • D.D. Adams et al.

    Occurrence in thyrotoxicosis of a gamma globulin which protects LATS from neutralization by an extract of thyroid gland

    J Clin Endocrinol Metab

    (1967)
  • A Albert

    The experimental production of exophthalmos in fundulus by means of pituitary extracts

    Endocrinology

    (1945)
  • S Almquist et al.

    Hypothyroidism in progressive ophthalmopathy of Graves' disease

    Acta Ophthalmol

    (1972)
  • H Aranow et al.

    Management of thyrotoxicosis in patients with ophthalmopathy: antithyroid regimen determined primarily by ocular manifestations

    J Clin Endocrinol Metab

    (1965)
  • J Barbosa et al.

    Ophthalmopathy of Graves' disease: outcome after treatment with radioactive iodine, surgery or antithyroid drugs

    Arch Intern Med

    (1972)
  • E.C. Bartels et al.

    Thyroid function in patients with progressive exophthalmos

  • G.N. Beall

    Clinical immunology of Hashimoto's disease

  • R.N. Berke

    A modified Krönlein operation

    Trans Am Ophthalmol Soc

    (1953)
  • C Bernard

    Compt Rend Soc Bio

    (1852)
  • S.T. Bigos et al.

    Cyclophosphamide in the management of advanced Graves' ophthalmopathy

    Ann Intern Med

    (1979)
  • D.M. Brown et al.

    Thyrotoxicosis occurring in two patients on prolonged high doses of steroid

    N Engl J Med

    (1964)
  • L Chess et al.

    Immunologic functions of isolated human lymphocyte populations. IV. Further characterization of the surface Ig negative, E rosette negative (null cell) subset

    J Immunol

    (1975)
  • I.J. Chopra et al.

    Specific and non-specific responses in the bioassay of long-acting thyroid stimulator (LATS)

    J Clin Endocrinol Metab

    (1970)
  • D.G. Cogan
  • M.D. Cooper et al.

    A developmental approach to the biological basis of antibody diversity

    Contemp Top Immunobiol

    (1972)
  • R.M. Day et al.

    Optic nerve involvement associated with thyroid dysfunction

    Arch Ophthalmol

    (1962)
  • RM Day et al.

    Corticosteroids in the treatment of optic nerve involvement associated with thyroid dysfunction

    Arch Ophthalmol

    (1968)
  • R.M. Day

    Hyperthyroidism: pathology of eye changes

  • R.M. Day

    Ocular manifestations of Graves' disease — therapeutic approaches

    Bull NY Acad Med

    (1977)
  • L.W. DeSanto

    Surgical palliation of ophthalmopathy of Graves' disease

  • A.M. DiGeorge

    Congenital absence of the thymus and its immunologic consequences: concurrence with congenital hypoparathyroidism

    Brith Defects

    (1968)
  • R.S. Dixon et al.

    The use of thymoxamine in eyelid retraction

    Arch Ophthalmol

    (1979)
  • S.S. Donaldson et al.

    Supervoltage orbital radiotherapy for Graves' ophthalmopathy

    J Clin Endocrinol Metab

    (1973)
  • R.M. Dryden et al.

    The use of scleral transplantation in cicatricial entropion and eyelid retraction

    Trans Am Acad Ophthalmol Otolaryngol

    (1977)
  • H.F. Dunlop et al.

    Psychic manifestations associated with hyperthyroidism

    Am J Psychiatr

    (1935)
  • N.R. Farid et al.

    Peripheral thymusderived (T) lymphocytes in Graves' disease and Hashimoto's thyroiditis

    N Engl J Med

    (1973)
  • H Folch et al.

    The splenic suppressor cell. II. Suppression of the mixed lymphocyte reaction by thymus-dependent adherent cells

    J Immunol

    (1974)
  • L Frisen

    Chorioretinal folds

  • L Frisen et al.

    Visual field defects associated with choroidal folds

  • J Furszyfer et al.

    On the increased association of Graves' disease with pernicious anemia

  • L.M. Graeler et al.

    Myasthenia gravis and thyroid function

    Arch Neurol

    (1968)
  • A.J. Gay et al.

    Topical sympatholytic therapy for pathologic lid retraction

    Arch Ophthalmol

    (1967)
  • A.J. Gay et al.

    Topical guanethidine therapy for endocrine lid retraction

    Arch Ophthalmol

    (1966)
  • R.K. Gershon

    T-cell control of antibody production

    Contemp Top Immunobiol

    (1974)
  • H Gharib et al.

    Diagnosis of Graves' ophthalmopathy without hyperthyroidism: long-acting thyroid stimulator (LATS) determination as laboratory adjunct

  • T.G. Gill

    Principles of radioimmunoassay

  • Cited by (79)

    • Endoscopic orbital decompression

      2011, Operative Techniques in Otolaryngology - Head and Neck Surgery
      Citation Excerpt :

      After the inflammatory process ends, fibrosis and the associated disabling symptoms persist in the stable, inactive phase. Immunomodulatory agents are believed to affect the activity of orbital lymphocytes and fibroblasts.7,8 The most commonly used immunomodulators include corticosteroids with or without adjunctive external beam orbital radiation (XRT) in moderate to severe cases of TED.

    • Compressive and infiltrative optic neuropathies

      2014, Optic Nerve Disorders: Diagnosis and Management
    View all citing articles on Scopus

    Part of the investigative work contained in this review was supported by National Eye Institute Grant EY 02631.

    1

    Dr. Sergott is the recipient of a National Research Service Award (EY 07021) from the National Eye Institute

    View full text